Furthermore, siRNA knockdown of GRM1 in human melanoma cell also resulted in a decrease in AKT2 phosphorylation corroborating that AKT2 is a downstream target of GRM1 (Wangari-Talbot et al., 2012). This evidence concerns the gene AKT2 and melanoma.